LivaNova (LIVN) Operating Income Growth (3y) (2017 - 2026)
LivaNova (LIVN) Operating Income Growth (3y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | -3.76% |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 8.39% |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 6.17% |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 25.88% |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 7.13% |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 75.54% |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | -2.70% |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 34.83% |
| 10 | LivaNova | 4.40 Bn | 3.86 Bn | 243.75 Mn | 170.11% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 170.11% |
| Dec 31, 2025 | 45.02% |
| Sep 30, 2025 | 34.06% |
| Jun 30, 2025 | 19.49% |
| Mar 31, 2025 | 72.30% |
| Dec 31, 2024 | 14.36% |
| Sep 30, 2024 | 29.44% |
| Jun 30, 2024 | 45.93% |
| Mar 31, 2024 | 69.28% |
| Dec 31, 2023 | 29.30% |
| Sep 30, 2023 | 37.34% |
| Jun 30, 2023 | 44.83% |
| Mar 31, 2023 | -59.15% |
| Dec 31, 2022 | 28.00% |
| Sep 30, 2022 | -92.41% |
| Jun 30, 2022 | 45.23% |
| Mar 31, 2022 | 34.95% |
| Dec 31, 2021 | 27.84% |
| Sep 30, 2021 | 69.30% |
| Jun 30, 2021 | -54.36% |